OpenAlex records ~96 works with ~5,471 citations and h-index 34 (Semantic Scholar data: 80 papers, h-index 30, 4,833 citations); the metrics are consistent across databases. His peak-cited works are methodologically formative in interactomics and systems biology: the 2000 Science two-hybrid interaction map (763 citations) , the 2012 Nature proto-genes/de novo gene birth paper (673 citations) , and the 2013 AJHG DNAH1 male-infertility paper (480 citations) . OpenAlex per-year counts show sustained productivity with a 2018 peak (~988 citations that year) and a shift from C. elegans/pooling/interactome methods (2000β2012) to a focused human male-infertility genetics program (2013βpresent).
His 2026 BFWalk preprint illustrates applied methodological strength: a non-backtracking, in-degree-normalized propagation algorithm benchmarked on a 17,638-protein human interactome against RWR and NetCore using leave-one-out cross-validation with Wilcoxon signed-rank tests. BFWalk significantly outperformed both comparators for MMAF (AUC 0.659 vs 0.468 and 0.565, p < 10β»β΄) and dyschromatopsia (0.660 vs 0.573 and 0.593), with no significant differences for cardiomyopathy or kidney disease, and Spearman Ο ~0.70β0.72 linking its advantage to low/intermediate-degree genes β an honest, quantitative anti-hub-bias analysis . Strengths: transparent statistics, pre-specified comparators, released code and validation scripts, declared no competing interests, and openly reported null/intermediate results. Limitations: computational-only validation, four phenotypes on one interactome, and AUC as a coarse global metric β claims stop at benchmark evidence.
The portfolio reveals a genuine systems-biology-to-human-genetics arc with several highly cited, independently verifiable discoveries. Blindspots: the dominant pattern is middle/last-adjacent authorship on consortium papers, so first-author intellectual ownership of the flagship works cannot be established from supplied data; his institution field is blank in OpenAlex (CNRS affiliation appears only via co-author records); and the BFWalk benchmark lacks experimental confirmation of novel candidates, a standard limitation for network-propagation methods. Overall: a scientifically credible, statistically careful researcher with strong methodological breadth (two-hybrid pooling design, interactome databases like MatrixDB, prion biology, clinical genomics) rather than a single-theme specialist. Confidence: moderate β based on three supplied sources, not an independent citation audit.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.